You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interferon-alpha

Showing 1 - 25 of 4,958
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Dysplasia, HPV Infection Trial in Ulaanbaatar (gel Interferon arm, gel Interferon and interferon suppository arm)

Recruiting
  • Cervical Dysplasia
  • HPV Infection
  • gel Interferon arm
  • gel Interferon and interferon suppository arm
  • Ulaanbaatar, Mongolia
    National Cancer Center
Nov 14, 2023

HPV Infection Trial (Human interferon alpha 2b vaginal Effervescent capsules)

Not yet recruiting
  • HPV Infection
  • Human interferon alpha 2b vaginal Effervescent capsules
  • (no location specified)
May 8, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Biopsy
  • +7 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 23, 2023

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

Recruiting
  • Hepatitis B, Chronic
  • PEGylated recombinant human interferon alpha-2b injection
  • Hefei, Anhui, China
    The First Affiliated Hospital of Anhui Medical University
Jun 24, 2023

Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before

Not yet recruiting
  • Herpes Zoster
  • Recombinant Human Interferon α-2b Gel (After the Alteration)
  • Recombinant Human Interferon α-2b Gel (Before the Alteration)
  • (no location specified)
Apr 7, 2023

COVID-19 Infection and Its Clinical Prognosis in Chronic

Recruiting
  • Chronic Hepatitis B
  • COVID-19 Infection
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023

Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

Recruiting
  • Essential Thrombocytopenia
  • Recombinant Interferon Alpha
  • Pegylated interferon alfa-2b
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 18, 2022

Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)

Not yet recruiting
  • Myelofibrosis
  • Pegylated interferon alpha2a
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Sep 6, 2022

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

Terminated
  • Hepatitis B, Chronic
  • Hillsborough, New Jersey
  • +11 more
Dec 28, 2022

Toxicity, Drug, Adverse Drug Event, Effects of Immunotherapy Trial in Leiden (Nivolumab & Tumor Infiltrating Lymphocytes

Recruiting
  • Toxicity, Drug
  • +2 more
  • Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha
  • Leiden, Netherlands
    Leiden University Medical Center
Aug 16, 2022

Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

Not yet recruiting
  • Angiosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2023

Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon

Active, not recruiting
  • HIV
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Coronavirus Disease 2019 Trial in Santiago (Interferon-Alpha2B, Placebo)

    Completed
    • Coronavirus Disease 2019
    • Santiago, RM, Chile
      Red de Salud UC Christus
    Aug 3, 2022

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +2 more
    • Best Practice
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Mar 1, 2022

    Polycythemia Vera Trial in London, Oxford (Ruxolitinib, Hydroxycarbamide, Interferon-Alpha)

    Recruiting
    • Polycythemia Vera
    • London, United Kingdom
    • +1 more
    Nov 29, 2021

    Sarcoma, Kaposi, HIV Trial in Miami (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

    Completed
    • Sarcoma, Kaposi
    • HIV Infections
    • Interferon alfa-2a
    • +2 more
    • Miami, Florida
      Univ of Miami School of Medicine
    Oct 27, 2021

    Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

    Completed
    • Sarcoma, Kaposi
    • HIV Infections
    • Interferon alfa-2a
    • +2 more
    • New York, New York
      Mem Sloan - Kettering Cancer Ctr
    Oct 28, 2021

    Neuroendocrine Tumors Trial in Besancon, Montbéliard (Metronomic cyclophosphamide, Interferon-alpha)

    Completed
    • Neuroendocrine Tumors
    • Metronomic cyclophosphamide
    • Interferon-alpha
    • Besancon, France
    • +1 more
    Jul 30, 2021

    Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

    Active, not recruiting
    • Lymphoproliferative Disorder
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

    Completed
    Has Results
    • Metastatic Carcinoma in the Liver
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Feb 25, 2022

    Chronic Hepatitis B Trial in Worldwide (VIR-2218, pegylated interferon-alfa 2a)

    Active, not recruiting
    • Chronic Hepatitis B
    • Birtinya, Queensland, Australia
    • +21 more
    Dec 20, 2021

    Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

    Completed
    Has Results
    • Juvenile Pilocytic Astrocytomas
    • Optic Pathway Gliomas
    • Pegylated interferon alpha-2b
    • Atlanta, Georgia
      Children's Healthcare of Atlanta
    Jan 18, 2022

    Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

    Recruiting
    • Stage III Hepatocellular Carcinoma AJCC v8
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 18, 2021

    Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

    Recruiting
    • Hematological Neoplasms
    • Recurrence
    • Peg interferon alfa-2b
    • Shanghai, Shanghai, China
      Shanghai Jiao Tong University Affilated First People's Hospital
    Oct 10, 2021